Predictors for long‐term survival after transcatheter edge‐to‐edge mitral valve repair

Objectives To determine predictors for long‐term outcome in high‐risk patients undergoing transcatheter edge‐to‐edge mitral valve repair (TMVR) for severe mitral regurgitation (MR). Background There is no data on predictors of long‐term outcome in high‐risk real‐world patients. Methods From August 2...

Full description

Saved in:
Bibliographic Details
Published inJournal of interventional cardiology Vol. 30; no. 3; pp. 226 - 233
Main Authors Orban, Mathias, Orban, Martin, Lesevic, Hasema, Braun, Daniel, Deseive, Simon, Sonne, Carolin, Hutterer, Lisa, Grebmer, Christian, Khandoga, Alexander, Pache, Jürgen, Mehilli, Julinda, Schunkert, Heribert, Kastrati, Adnan, Hagl, Christian, Bauer, Axel, Massberg, Steffen, Boekstegers, Peter, Nabauer, Michael, Ott, Ilka, Hausleiter, Jörg
Format Journal Article
LanguageEnglish
Published United States Hindawi Limited 01.06.2017
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Objectives To determine predictors for long‐term outcome in high‐risk patients undergoing transcatheter edge‐to‐edge mitral valve repair (TMVR) for severe mitral regurgitation (MR). Background There is no data on predictors of long‐term outcome in high‐risk real‐world patients. Methods From August 2009 to April 2011, 126 high‐risk patients deemed inoperable were treated with TMVR in two high‐volume university centers. Results MR could be successfully reduced to grade ≤2 in 92.1% of patients (116/126 patients). Long‐term clinical follow‐up up to 5 years (95.2% follow‐up rate) revealed a mortality rate of 35.7% (45/126 patients). Repeat mitral valve treatment (surgery or intervention) was needed in 19 patients (15.1%). Long‐term clinical improvement was demonstrated with 69% of patients being in NYHA class ≤II. In a multivariable Cox regression analysis, the post‐procedural grade of MR (hazard ratio [HR] 1.55 per grade, P = 0.035), the left ventricular ejection fraction (HR 0.58 for difference between 75th and 25th percentile, P = 0.031) and the glomerular filtration rate (HR 0.33 for 75th vs 25th percentile, P < 0.001) were independent predictors for long‐term mortality. Patients with primary MR and a post‐procedural MR grade ≤1 had the most favorable long‐term outcome. Conclusions This study determines predictors of long‐term clinical outcome after TMVR and demonstrates that the grade of residual MR determines long‐term survival. Our data suggest that it might be of benefit reducing residual MR to the lowest possible MR grade using TMVR—especially in selected high‐risk patients with primary MR who are not considered as candidates for surgical MVR.
AbstractList Objectives To determine predictors for long‐term outcome in high‐risk patients undergoing transcatheter edge‐to‐edge mitral valve repair (TMVR) for severe mitral regurgitation (MR). Background There is no data on predictors of long‐term outcome in high‐risk real‐world patients. Methods From August 2009 to April 2011, 126 high‐risk patients deemed inoperable were treated with TMVR in two high‐volume university centers. Results MR could be successfully reduced to grade ≤2 in 92.1% of patients (116/126 patients). Long‐term clinical follow‐up up to 5 years (95.2% follow‐up rate) revealed a mortality rate of 35.7% (45/126 patients). Repeat mitral valve treatment (surgery or intervention) was needed in 19 patients (15.1%). Long‐term clinical improvement was demonstrated with 69% of patients being in NYHA class ≤II. In a multivariable Cox regression analysis, the post‐procedural grade of MR (hazard ratio [HR] 1.55 per grade, P = 0.035), the left ventricular ejection fraction (HR 0.58 for difference between 75th and 25th percentile, P = 0.031) and the glomerular filtration rate (HR 0.33 for 75th vs 25th percentile, P < 0.001) were independent predictors for long‐term mortality. Patients with primary MR and a post‐procedural MR grade ≤1 had the most favorable long‐term outcome. Conclusions This study determines predictors of long‐term clinical outcome after TMVR and demonstrates that the grade of residual MR determines long‐term survival. Our data suggest that it might be of benefit reducing residual MR to the lowest possible MR grade using TMVR—especially in selected high‐risk patients with primary MR who are not considered as candidates for surgical MVR.
Objectives To determine predictors for long‐term outcome in high‐risk patients undergoing transcatheter edge‐to‐edge mitral valve repair (TMVR) for severe mitral regurgitation (MR). Background There is no data on predictors of long‐term outcome in high‐risk real‐world patients. Methods From August 2009 to April 2011, 126 high‐risk patients deemed inoperable were treated with TMVR in two high‐volume university centers. Results MR could be successfully reduced to grade ≤2 in 92.1% of patients (116/126 patients). Long‐term clinical follow‐up up to 5 years (95.2% follow‐up rate) revealed a mortality rate of 35.7% (45/126 patients). Repeat mitral valve treatment (surgery or intervention) was needed in 19 patients (15.1%). Long‐term clinical improvement was demonstrated with 69% of patients being in NYHA class ≤II. In a multivariable Cox regression analysis, the post‐procedural grade of MR (hazard ratio [HR] 1.55 per grade, P  = 0.035), the left ventricular ejection fraction (HR 0.58 for difference between 75th and 25th percentile, P  = 0.031) and the glomerular filtration rate (HR 0.33 for 75th vs 25th percentile, P  < 0.001) were independent predictors for long‐term mortality. Patients with primary MR and a post‐procedural MR grade ≤1 had the most favorable long‐term outcome. Conclusions This study determines predictors of long‐term clinical outcome after TMVR and demonstrates that the grade of residual MR determines long‐term survival. Our data suggest that it might be of benefit reducing residual MR to the lowest possible MR grade using TMVR—especially in selected high‐risk patients with primary MR who are not considered as candidates for surgical MVR.
OBJECTIVESTo determine predictors for long-term outcome in high-risk patients undergoing transcatheter edge-to-edge mitral valve repair (TMVR) for severe mitral regurgitation (MR).BACKGROUNDThere is no data on predictors of long-term outcome in high-risk real-world patients.METHODSFrom August 2009 to April 2011, 126 high-risk patients deemed inoperable were treated with TMVR in two high-volume university centers.RESULTSMR could be successfully reduced to grade ≤2 in 92.1% of patients (116/126 patients). Long-term clinical follow-up up to 5 years (95.2% follow-up rate) revealed a mortality rate of 35.7% (45/126 patients). Repeat mitral valve treatment (surgery or intervention) was needed in 19 patients (15.1%). Long-term clinical improvement was demonstrated with 69% of patients being in NYHA class ≤II. In a multivariable Cox regression analysis, the post-procedural grade of MR (hazard ratio [HR] 1.55 per grade, P = 0.035), the left ventricular ejection fraction (HR 0.58 for difference between 75th and 25th percentile, P = 0.031) and the glomerular filtration rate (HR 0.33 for 75th vs 25th percentile, P < 0.001) were independent predictors for long-term mortality. Patients with primary MR and a post-procedural MR grade ≤1 had the most favorable long-term outcome.CONCLUSIONSThis study determines predictors of long-term clinical outcome after TMVR and demonstrates that the grade of residual MR determines long-term survival. Our data suggest that it might be of benefit reducing residual MR to the lowest possible MR grade using TMVR-especially in selected high-risk patients with primary MR who are not considered as candidates for surgical MVR.
To determine predictors for long-term outcome in high-risk patients undergoing transcatheter edge-to-edge mitral valve repair (TMVR) for severe mitral regurgitation (MR). There is no data on predictors of long-term outcome in high-risk real-world patients. From August 2009 to April 2011, 126 high-risk patients deemed inoperable were treated with TMVR in two high-volume university centers. MR could be successfully reduced to grade ≤2 in 92.1% of patients (116/126 patients). Long-term clinical follow-up up to 5 years (95.2% follow-up rate) revealed a mortality rate of 35.7% (45/126 patients). Repeat mitral valve treatment (surgery or intervention) was needed in 19 patients (15.1%). Long-term clinical improvement was demonstrated with 69% of patients being in NYHA class ≤II. In a multivariable Cox regression analysis, the post-procedural grade of MR (hazard ratio [HR] 1.55 per grade, P = 0.035), the left ventricular ejection fraction (HR 0.58 for difference between 75th and 25th percentile, P = 0.031) and the glomerular filtration rate (HR 0.33 for 75th vs 25th percentile, P < 0.001) were independent predictors for long-term mortality. Patients with primary MR and a post-procedural MR grade ≤1 had the most favorable long-term outcome. This study determines predictors of long-term clinical outcome after TMVR and demonstrates that the grade of residual MR determines long-term survival. Our data suggest that it might be of benefit reducing residual MR to the lowest possible MR grade using TMVR-especially in selected high-risk patients with primary MR who are not considered as candidates for surgical MVR.
Objectives To determine predictors for long-term outcome in high-risk patients undergoing transcatheter edge-to-edge mitral valve repair (TMVR) for severe mitral regurgitation (MR). Background There is no data on predictors of long-term outcome in high-risk real-world patients. Methods From August 2009 to April 2011, 126 high-risk patients deemed inoperable were treated with TMVR in two high-volume university centers. Results MR could be successfully reduced to grade ≤2 in 92.1% of patients (116/126 patients). Long-term clinical follow-up up to 5 years (95.2% follow-up rate) revealed a mortality rate of 35.7% (45/126 patients). Repeat mitral valve treatment (surgery or intervention) was needed in 19 patients (15.1%). Long-term clinical improvement was demonstrated with 69% of patients being in NYHA class ≤II. In a multivariable Cox regression analysis, the post-procedural grade of MR (hazard ratio [HR] 1.55 per grade, P=0.035), the left ventricular ejection fraction (HR 0.58 for difference between 75th and 25th percentile, P=0.031) and the glomerular filtration rate (HR 0.33 for 75th vs 25th percentile, P<0.001) were independent predictors for long-term mortality. Patients with primary MR and a post-procedural MR grade ≤1 had the most favorable long-term outcome. Conclusions This study determines predictors of long-term clinical outcome after TMVR and demonstrates that the grade of residual MR determines long-term survival. Our data suggest that it might be of benefit reducing residual MR to the lowest possible MR grade using TMVR--especially in selected high-risk patients with primary MR who are not considered as candidates for surgical MVR.
Author Hagl, Christian
Khandoga, Alexander
Lesevic, Hasema
Orban, Martin
Ott, Ilka
Deseive, Simon
Hutterer, Lisa
Schunkert, Heribert
Mehilli, Julinda
Kastrati, Adnan
Pache, Jürgen
Braun, Daniel
Sonne, Carolin
Orban, Mathias
Bauer, Axel
Grebmer, Christian
Boekstegers, Peter
Hausleiter, Jörg
Nabauer, Michael
Massberg, Steffen
Author_xml – sequence: 1
  givenname: Mathias
  orcidid: 0000-0001-7846-8808
  surname: Orban
  fullname: Orban, Mathias
  organization: Technische Universität München
– sequence: 2
  givenname: Martin
  orcidid: 0000-0001-9830-1941
  surname: Orban
  fullname: Orban, Martin
  email: martinorban@gmail.com
  organization: Technische Universität München
– sequence: 3
  givenname: Hasema
  surname: Lesevic
  fullname: Lesevic, Hasema
  organization: Technische Universität München
– sequence: 4
  givenname: Daniel
  surname: Braun
  fullname: Braun, Daniel
  organization: Technische Universität München
– sequence: 5
  givenname: Simon
  surname: Deseive
  fullname: Deseive, Simon
  organization: Technische Universität München
– sequence: 6
  givenname: Carolin
  surname: Sonne
  fullname: Sonne, Carolin
  organization: Technische Universität München
– sequence: 7
  givenname: Lisa
  surname: Hutterer
  fullname: Hutterer, Lisa
  organization: Ludwig‐Maximilians‐Universität München
– sequence: 8
  givenname: Christian
  surname: Grebmer
  fullname: Grebmer, Christian
  organization: Technische Universität München
– sequence: 9
  givenname: Alexander
  surname: Khandoga
  fullname: Khandoga, Alexander
  organization: Technische Universität München
– sequence: 10
  givenname: Jürgen
  surname: Pache
  fullname: Pache, Jürgen
  organization: Starnberg‐Berg
– sequence: 11
  givenname: Julinda
  surname: Mehilli
  fullname: Mehilli, Julinda
  organization: partner site Munich Heart Alliance
– sequence: 12
  givenname: Heribert
  surname: Schunkert
  fullname: Schunkert, Heribert
  organization: partner site Munich Heart Alliance
– sequence: 13
  givenname: Adnan
  surname: Kastrati
  fullname: Kastrati, Adnan
  organization: partner site Munich Heart Alliance
– sequence: 14
  givenname: Christian
  surname: Hagl
  fullname: Hagl, Christian
  organization: Ludwig‐Maximilians‐Universität München
– sequence: 15
  givenname: Axel
  surname: Bauer
  fullname: Bauer, Axel
  organization: Ludwig‐Maximilians‐Universität München
– sequence: 16
  givenname: Steffen
  surname: Massberg
  fullname: Massberg, Steffen
  organization: partner site Munich Heart Alliance
– sequence: 17
  givenname: Peter
  surname: Boekstegers
  fullname: Boekstegers, Peter
  organization: HELIOS Klinikum Siegburg
– sequence: 18
  givenname: Michael
  surname: Nabauer
  fullname: Nabauer, Michael
  organization: Ludwig‐Maximilians‐Universität München
– sequence: 19
  givenname: Ilka
  surname: Ott
  fullname: Ott, Ilka
  organization: Technische Universität München
– sequence: 20
  givenname: Jörg
  surname: Hausleiter
  fullname: Hausleiter, Jörg
  organization: Technische Universität München
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28370526$$D View this record in MEDLINE/PubMed
BookMark eNp90MtKAzEUBuAgFXvRjQ8gA25EmJrLXDJLKV4qBV3oTghp5qROmZnUZKbSnY_gM_okZmx14cIskhz4-Dn8Q9SrTQ0IHRM8Jv5cLE2hxoSyNNlDAxJHOOSEsx4aYJ4lYcRo2kdD55YYUxzH9AD1KWcpjmkyQM8PFvJCNca6QBsblKZefL5_NGCrwLV2XaxlGUjt56CxsnZKNi_QTZAvoIPGX90_qAoPysD7NQQWVrKwh2hfy9LB0e4doafrq8fJbTi7v5lOLmehYnGahHE0l1qxeaZozjiLNac0k_NESUi0xBnXUuVUyYRiCUB1pFIGmvI4zwhjVLIROtvmrqx5bcE1oiqcgrKUNZjWCcJ5RJKMYOLp6R-6NK2t_XaCZL4ezDKMvTrfKmWNcxa0WNmiknYjCBZd56LrXHx37vHJLrKdV5D_0p-SPSBb8FaUsPknStzdTyfb0C_kYZHm
CitedBy_id crossref_primary_10_1016_j_crvasa_2018_07_006
crossref_primary_10_1016_j_jcin_2020_02_028
crossref_primary_10_1016_j_jcin_2020_09_035
crossref_primary_10_1093_ehjci_jead210
crossref_primary_10_4244_EIJ_D_19_00718
crossref_primary_10_1016_j_jcin_2022_12_015
crossref_primary_10_3390_jcm10204748
crossref_primary_10_1016_j_ijcard_2024_132317
crossref_primary_10_1016_j_jcin_2023_02_029
crossref_primary_10_1111_eci_13473
crossref_primary_10_3390_jcm10225448
crossref_primary_10_1016_j_jcin_2020_09_050
crossref_primary_10_1016_j_jcmg_2018_02_024
crossref_primary_10_1053_j_semtcvs_2021_07_030
crossref_primary_10_1007_s12928_019_00610_z
crossref_primary_10_20517_2574_1225_2020_69
crossref_primary_10_1080_17434440_2020_1714433
crossref_primary_10_1016_j_ahj_2019_06_015
crossref_primary_10_1016_j_jacc_2021_11_041
crossref_primary_10_1016_j_jcin_2019_10_023
crossref_primary_10_1016_j_jcin_2019_09_014
crossref_primary_10_1016_j_jscai_2022_100495
crossref_primary_10_1016_j_jcin_2019_04_019
crossref_primary_10_1002_ejhf_1774
crossref_primary_10_1007_s00392_021_01961_5
crossref_primary_10_1016_j_jcin_2021_06_005
crossref_primary_10_4244_AIJ_D_22_00049
crossref_primary_10_1016_j_hlc_2021_11_017
crossref_primary_10_1016_j_jcmg_2022_02_017
crossref_primary_10_4244_EIJ_D_17_01136
crossref_primary_10_1016_j_carrev_2021_05_020
crossref_primary_10_1016_j_jcin_2020_12_042
crossref_primary_10_1016_j_carrev_2021_11_012
crossref_primary_10_1016_j_jcin_2022_01_277
crossref_primary_10_37615_retic_v6n1a2
crossref_primary_10_1002_ccd_30245
crossref_primary_10_1016_j_jcin_2019_03_023
crossref_primary_10_1016_j_amjcard_2020_06_025
crossref_primary_10_3390_diagnostics13152470
crossref_primary_10_1016_j_echo_2018_01_012
crossref_primary_10_1161_CIRCULATIONAHA_120_053061
crossref_primary_10_1016_j_jcmg_2020_08_019
crossref_primary_10_3389_fcvm_2020_546279
crossref_primary_10_1007_s00392_018_1365_5
Cites_doi 10.4244/EIJV8I12A211
10.1093/eurjhf/hfs214
10.1111/1755-5922.12058
10.1016/S0735-1097(85)80418-6
10.1111/joic.12193
10.1093/eurjhf/hfr029
10.4244/EIJV10I2A41
10.1002/ccd.25331
10.1016/0002-9149(85)90574-0
10.1016/S0894-7317(03)00335-3
10.1056/NEJMoa1009355
10.4244/EIJY15M09_07
10.1016/j.jacc.2015.10.018
10.1001/archinte.167.22.2490
10.1093/eurheartj/eht386
10.1093/eurheartj/ehi555
10.1161/hc37t1.094903
10.1093/eurheartj/ehv627
10.1016/j.athoracsur.2008.01.079
10.1136/openhrt-2014-000056
ContentType Journal Article
Copyright 2017, Wiley Periodicals, Inc.
2017 Wiley Periodicals, Inc.
Copyright_xml – notice: 2017, Wiley Periodicals, Inc.
– notice: 2017 Wiley Periodicals, Inc.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
H94
K9.
7X8
DOI 10.1111/joic.12376
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Immunology Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList
CrossRef
MEDLINE - Academic
MEDLINE
AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1540-8183
EndPage 233
ExternalDocumentID 10_1111_joic_12376
28370526
JOIC12376
Genre article
Journal Article
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
24P
29K
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
7X7
8-0
8-1
8-3
8-4
8-5
8FI
8FJ
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAJEY
AAONW
AAWTL
AAZKR
ABCQN
ABDBF
ABEML
ABJNI
ABOCM
ABPVW
ABUWG
ACBWZ
ACCFJ
ACGFS
ACMXC
ACPRK
ACSCC
ACXQS
ADBBV
ADEOM
ADIZJ
AEEZP
AEIMD
AENEX
AEQDE
AEUQT
AFBPY
AFEBI
AFKRA
AFPWT
AFZJQ
AHEFC
AIWBW
AJBDE
ALAGY
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMBMR
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BCNDV
BDRZF
BENPR
BHBCM
BMXJE
BPHCQ
BPMNR
BROTX
BRXPI
BVXVI
BY8
CAG
CCPQU
COF
CS3
D-6
D-7
D-E
D-F
D-I
DC6
DCZOG
DPXWK
DR2
DU5
EAD
EAP
EAS
EBD
EBS
EJD
EMB
EMK
EMOBN
ENC
EPT
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FYUFA
FZ0
G-S
G.N
GODZA
GROUPED_DOAJ
H.X
HF~
HMCUK
HVGLF
HYE
HZI
HZ~
IAO
IHE
IHR
INH
IX1
J0M
K48
LC2
LC3
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2W
P2X
P2Z
P4B
P4D
PALCI
PGMZT
PIMPY
PQQKQ
Q.N
Q11
QB0
Q~Q
R.K
RHX
RIWAO
RJQFR
ROL
RPM
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
UKHRP
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
ZZTAW
~IA
~WT
CGR
CUY
CVF
ECM
EIF
ITC
NPM
AAYXX
CITATION
7T5
H94
K9.
7X8
ID FETCH-LOGICAL-c3576-54bafc3b9c2d3835f8229ab6cae6fa098facd2ca620aee2f4c73ef285d91332a3
IEDL.DBID DR2
ISSN 0896-4327
IngestDate Fri Oct 25 01:30:00 EDT 2024
Thu Oct 10 17:48:45 EDT 2024
Thu Sep 26 18:49:18 EDT 2024
Sat Sep 28 08:45:48 EDT 2024
Sat Aug 24 01:11:49 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords percutaneous edge-to-edge mitral valve repair
heart failure
MitraClip
mitral valve regurgitation
functional mitral regurgitation
transcatheter edge-to-edge mitral valve repair
Language English
License 2017, Wiley Periodicals, Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3576-54bafc3b9c2d3835f8229ab6cae6fa098facd2ca620aee2f4c73ef285d91332a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-7846-8808
0000-0001-9830-1941
PMID 28370526
PQID 1920503900
PQPubID 2045134
PageCount 8
ParticipantIDs proquest_miscellaneous_1884169101
proquest_journals_1920503900
crossref_primary_10_1111_joic_12376
pubmed_primary_28370526
wiley_primary_10_1111_joic_12376_JOIC12376
PublicationCentury 2000
PublicationDate June 2017
2017-Jun
2017-06-00
20170601
PublicationDateYYYYMMDD 2017-06-01
PublicationDate_xml – month: 06
  year: 2017
  text: June 2017
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle Journal of interventional cardiology
PublicationTitleAlternate J Interv Cardiol
PublicationYear 2017
Publisher Hindawi Limited
Publisher_xml – name: Hindawi Limited
References 2014; 1
2007; 167
2013; 15
2015; 28
1985; 5
2006; 27
2015; 66
2003; 16
2014; 35
2011; 13
2008; 85
2013; 8
2014; 84
1985; 56
2016; 37
2001; 104
2011; 364
2014; 32
2014; 10
2016; 12
e_1_2_8_17_1
e_1_2_8_18_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_14_1
e_1_2_8_15_1
e_1_2_8_16_1
e_1_2_8_3_1
e_1_2_8_2_1
e_1_2_8_5_1
e_1_2_8_4_1
e_1_2_8_7_1
e_1_2_8_6_1
e_1_2_8_9_1
e_1_2_8_8_1
e_1_2_8_20_1
e_1_2_8_10_1
e_1_2_8_21_1
e_1_2_8_11_1
e_1_2_8_12_1
References_xml – volume: 27
  start-page: 65
  year: 2006
  end-page: 75
  article-title: Predictors of mortality and morbidity in patients with chronic heart failure
  publication-title: Eur Heart J
– volume: 104
  start-page: I1
  year: 2001
  end-page: I7
  article-title: Very long‐term survival and durability of mitral valve repair for mitral valve prolapse
  publication-title: Circulation
– volume: 66
  start-page: 2844
  year: 2015
  end-page: 2854
  article-title: Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5‐year results of EVEREST II
  publication-title: J Am Coll Cardiol
– volume: 85
  start-page: 1537
  year: 2008
  end-page: 1542
  article-title: Recurrent mitral regurgitation and risk factors for early and late mortality after mitral valve repair for functional ischemic mitral regurgitation
  publication-title: Ann Thorac Surg
– volume: 5
  start-page: 811
  year: 1985
  end-page: 826
  article-title: Afterload mismatch in aortic and mitral valve disease: implications for surgical therapy
  publication-title: J Am Coll Cardiol
– volume: 32
  start-page: 66
  year: 2014
  end-page: 73
  article-title: Percutaneous mitral repair with the MitraClip system in patients with mild‐to‐moderate and severe heart failure: a single‐centre experience
  publication-title: Cardiovasc Ther
– volume: 13
  start-page: 569
  year: 2011
  end-page: 576
  article-title: MitraClip(R) therapy in patients with end‐stage systolic heart failure
  publication-title: Eur J Heart Fail
– volume: 167
  start-page: 2490
  year: 2007
  end-page: 2496
  article-title: Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: the HUNT II Study
  publication-title: Arch Intern Med
– volume: 1
  start-page: e000056
  year: 2014
  article-title: Two‐year outcomes after percutaneous mitral valve repair with the MitraClip system: durability of the procedure and predictors of outcome
  publication-title: Open Heart
– volume: 56
  start-page: 99
  year: 1985
  end-page: 105
  article-title: Left ventricular stress‐dimension‐shortening relations before and after correction of chronic aortic and mitral regurgitation
  publication-title: Am J Cardiol
– volume: 10
  start-page: 253
  year: 2014
  end-page: 259
  article-title: Dangerous liaison: successful percutaneous edge‐to‐edge mitral valve repair in patients with end‐stage systolic heart failure can cause left ventricular thrombus formation
  publication-title: EuroIntervention
– volume: 35
  start-page: 455
  year: 2014
  end-page: 469
  article-title: Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta‐analysis
  publication-title: Eur Heart J
– volume: 12
  start-page: 508
  year: 2016
  end-page: 514
  article-title: Predictors for short‐term outcomes of patients undergoing transcatheter mitral valve interventions: analysis of 778 prospective patients from the German TRAMI registry focusing on baseline renal function
  publication-title: EuroIntervention
– volume: 364
  start-page: 1395
  year: 2011
  end-page: 1406
  article-title: Percutaneous repair or surgery for mitral regurgitation
  publication-title: N Eng J Med
– volume: 15
  start-page: 786
  year: 2013
  end-page: 795
  article-title: Patient selection criteria and midterm clinical outcome for MitraClip therapy in patients with severe mitral regurgitation and severe congestive heart failure
  publication-title: Eur J Heart Fail
– volume: 8
  start-page: 1379
  year: 2013
  end-page: 1387
  article-title: Three‐dimensional transoesophageal echocardiography for the assessment of clip attachment to the leaflets in percutaneous edge‐to‐edge repair of the mitral valve
  publication-title: EuroIntervention
– volume: 84
  start-page: 137
  year: 2014
  end-page: 146
  article-title: Percutaneous edge‐to‐edge repair of the mitral valve in patients with degenerative versus functional mitral regurgitation
  publication-title: Catheter Cardiovasc Interv
– volume: 28
  start-page: 164
  year: 2015
  end-page: 171
  article-title: Long‐term outcome of patients with severe biventricular heart failure and severe mitral regurgitation after percutaneous edge‐to‐edge mitral valve repair
  publication-title: J Interv Cardiol
– volume: 37
  start-page: 703
  year: 2016
  end-page: 712
  article-title: One‐year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry
  publication-title: Eur Heart J
– volume: 16
  start-page: 777
  year: 2003
  end-page: 802
  article-title: Recommendations for evaluation of the severity of native valvular regurgitation with two‐dimensional and Doppler echocardiography
  publication-title: J Am Soc Echocardiogr
– ident: e_1_2_8_4_1
  doi: 10.4244/EIJV8I12A211
– ident: e_1_2_8_15_1
  doi: 10.1093/eurjhf/hfs214
– ident: e_1_2_8_8_1
  doi: 10.1111/1755-5922.12058
– ident: e_1_2_8_12_1
  doi: 10.1016/S0735-1097(85)80418-6
– ident: e_1_2_8_17_1
  doi: 10.1111/joic.12193
– ident: e_1_2_8_16_1
  doi: 10.1093/eurjhf/hfr029
– ident: e_1_2_8_13_1
  doi: 10.4244/EIJV10I2A41
– ident: e_1_2_8_10_1
  doi: 10.1002/ccd.25331
– ident: e_1_2_8_11_1
  doi: 10.1016/0002-9149(85)90574-0
– ident: e_1_2_8_5_1
  doi: 10.1016/S0894-7317(03)00335-3
– ident: e_1_2_8_2_1
  doi: 10.1056/NEJMoa1009355
– ident: e_1_2_8_21_1
  doi: 10.4244/EIJY15M09_07
– ident: e_1_2_8_3_1
  doi: 10.1016/j.jacc.2015.10.018
– ident: e_1_2_8_19_1
  doi: 10.1001/archinte.167.22.2490
– ident: e_1_2_8_20_1
  doi: 10.1093/eurheartj/eht386
– ident: e_1_2_8_14_1
  doi: 10.1093/eurheartj/ehi555
– ident: e_1_2_8_6_1
  doi: 10.1161/hc37t1.094903
– ident: e_1_2_8_18_1
  doi: 10.1093/eurheartj/ehv627
– ident: e_1_2_8_9_1
  doi: 10.1016/j.athoracsur.2008.01.079
– ident: e_1_2_8_7_1
  doi: 10.1136/openhrt-2014-000056
SSID ssj0020552
Score 2.3746016
Snippet Objectives To determine predictors for long‐term outcome in high‐risk patients undergoing transcatheter edge‐to‐edge mitral valve repair (TMVR) for severe...
To determine predictors for long-term outcome in high-risk patients undergoing transcatheter edge-to-edge mitral valve repair (TMVR) for severe mitral...
Objectives To determine predictors for long-term outcome in high-risk patients undergoing transcatheter edge-to-edge mitral valve repair (TMVR) for severe...
OBJECTIVESTo determine predictors for long-term outcome in high-risk patients undergoing transcatheter edge-to-edge mitral valve repair (TMVR) for severe...
SourceID proquest
crossref
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 226
SubjectTerms Aged
Cardiac Catheterization - methods
Cardiac Catheterization - statistics & numerical data
Catheters
Female
functional mitral regurgitation
Germany - epidemiology
Glomerular filtration rate
Heart
heart failure
Heart Valve Prosthesis Implantation - adverse effects
Heart Valve Prosthesis Implantation - methods
Heart Valve Prosthesis Implantation - mortality
Humans
Long Term Adverse Effects - mortality
Long Term Adverse Effects - surgery
Male
Middle Aged
MitraClip
Mitral valve
Mitral Valve - surgery
Mitral Valve Insufficiency - diagnosis
Mitral Valve Insufficiency - physiopathology
Mitral Valve Insufficiency - surgery
mitral valve regurgitation
Mortality
percutaneous edge‐to‐edge mitral valve repair
Proportional Hazards Models
Regurgitation
Risk Adjustment - methods
Risk Factors
Risk groups
Severity of Illness Index
Surgery
Survival
transcatheter edge‐to‐edge mitral valve repair
Treatment Outcome
Ventricle
Ventricular Function, Left
Title Predictors for long‐term survival after transcatheter edge‐to‐edge mitral valve repair
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjoic.12376
https://www.ncbi.nlm.nih.gov/pubmed/28370526
https://www.proquest.com/docview/1920503900
https://search.proquest.com/docview/1884169101
Volume 30
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4hDohLKY-WpYCM4FQpq8SOvYnEBfEQRYJWVZE4tIpsx0YrIKn20QMnfgK_kV_CjJONSitVKpfIUSa24_F4Hp58BtgTWklhsjQSNvFRKnwc5aX3kSszkXml0yzEIc8v1OllenYlr-Zgf_YvTIMP0QXcSDLCek0Crs34dyGvh7afUFIHLsCJGFA-19HXDjuKxzIctxNnucI-8EGLTRrSeLpXX2qjv0zMlxZrUDknS_Bj1tkm0-SmP52Yvr3_A8fxtV_zFt60tig7aCbPMsy5agUWztvd9lX4_mVEZTqPh6Fty27r6vrp4ZEWczae4hqDs5SFQ8bZhFRegIClO4rREWGNFyqzuyEFVBjS_3JshBpwOFqDy5Pjb4enUXsaQ2QFOiWRTI32Vpjc8hLdWukJKl4bZbVTXsd55rUtudWKx9o57lM7EM7zTJY5-sFci3cwX9WVWwdmkNBJOTBWYa2JMej3JQqJvcMhsLwHuzOuFD8b0I2ic1ZwoIowUD3YnDGsaAVvXKDBSgg3eRz3YKd7jCJD-yC6cvUUaTLaa0U7KenB-4bRXTMBDEhyrPxjYNc_2i_OPn86DKWN_yH-AIucTIMQydmE-clo6rbQsJmY7TCBnwHyy_gM
link.rule.ids 315,783,787,1378,27936,27937,46306,46730
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB7BIhUuPFpaFkoxoiekrBI79ibHqg9tH1sQaqUekCLbsatVIUH74MCJn9Df2F_SGSeNKEhI7SVylEmceDyehyffAGwKraQwWRoJm_goFT6O8tL7yJWZyLzSaRbikONjNTpND87kWZubQ__CNPgQXcCNJCOs1yTgFJD-U8rriR0klNXxEB6hvAuq3LDzpUOP4rEMBXfiLFf4FnzYopOGRJ7u3tv66B8j87bNGpTO3rOmsuosYBVSrsnFYDE3A_vrLyTHe3_Pc3jamqNsq5k_L-CBq5ZhadxuuK_A189TalNJHobmLftWV-dXvy9pPWezBS4zOFFZqDPO5qT1AgosnVGYjghrPFCbfZ9QTIUh_U_HpqgEJ9OXcLq3e7I9itqCDJEV6JdEMjXaW2Fyy0v0bKUntHhtlNVOeR3nmde25FYrHmvnuE_tUDjPM1nm6ApzLVahV9WVewXMIKGTcmiswqcmxqDrlygk9g6HwPI-fLhhS_Gjwd0oOn8FB6oIA9WH9RuOFa3szQq0WQnkJo_jPrzvLqPU0FaIrly9QJqMtlvRVEr6sNZwuusm4AFJjg__GPj1n_6Lg0_726H1-i7E7-Dx6GR8VBztHx--gSecLIUQ2FmH3ny6cG_RzpmbjTCbrwFU0vwk
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NTtwwEB5RKqFeoAVKl9LWiJ4qZZXYsTeReqloV0D5U1UkDq0i27GrFZCgZZcDpz5Cn5EnYcbJRqVIldpL5CgT27E9nm_GzmeAt0IrKUyWRsImPkqFj6O89D5yZSYyr3SahTjkwaHaOUn3TuXpHLyf_QvT8EN0ATfSjDBfk4Jflv53Ja9Htp_Qpo5H8DhVCH0JEn3pyKN4LMN5O3GWK6wEH7TkpGEfT_fufXP0AGPeh6zB5gyX4Pusts1Wk7P-dGL69uYPIsf__ZynsNiCUfahGT3PYM5Vy7Bw0C63r8C34zGl6UAehuCWndfVj9ufv2g2Z1dTnGRwmLJwyjibkM0LHLB0R0E6EqzxQml2MaKICkP5a8fGaAJH41U4GX76ur0TtccxRFagVxLJ1GhvhcktL9GvlZ644rVRVjvldZxnXtuSW614rJ3jPrUD4TzPZJmjI8y1eA7zVV25F8AMCjopB8YqzDUxBh2_RKGwd9gElvdga9YrxWXDulF03go2VBEaqgcbsw4rWs27KhCxEsVNHsc92Oweo87QQoiuXD1FmYwWWxEoJT1Yazq6KyawAUmOmb8L3fWX8ou9o93tkFr_F-E3sHD8cVjs7x5-fglPOMGEENXZgPnJeOpeIciZmNdhLN8BdZr60w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Predictors+for+long-term+survival+after+transcatheter+edge-to-edge+mitral+valve+repair&rft.jtitle=Journal+of+interventional+cardiology&rft.au=Orban%2C+Mathias&rft.au=Orban%2C+Martin&rft.au=Lesevic%2C+Hasema&rft.au=Braun%2C+Daniel&rft.date=2017-06-01&rft.eissn=1540-8183&rft.volume=30&rft.issue=3&rft.spage=226&rft_id=info:doi/10.1111%2Fjoic.12376&rft_id=info%3Apmid%2F28370526&rft.externalDocID=28370526
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0896-4327&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0896-4327&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0896-4327&client=summon